2020 Annual General Meeting and General Meeting

1. To receive and consider the Company’s 2019 Annual report and accounts

2,522,665,591

99.99

365,256

0.01

64.24%

10,417,037

2. To approve the Directors’ remuneration report in the Company’s 2019 Annual report and accounts

2,426,163,368

95.84

105,081,885

4.16

64.45%

2,308,589

3. 

4. To elect Amanda Blanc

2,528,794,266

99.85

3,689,386

0.15

64.48%

1,082,243

5. To elect George Culmer

2,523,673,163

99.65

8,822,259

0.35

64.48%

1,080,243

6. To elect Patrick Flynn

2,525,403,956

99.72

7,049,868

0.28

64.48%

1,115,758

7. To elect Jason Windsor

2,516,821,427

99.38

15,628,741

0.62

64.48%

1,123,662

8. To re-elect Patricia Cross

2,504,449,879

98.89

28,095,545

1.11

64.48%

1,020,691

9. To re-elect Belén Romana García

2,507,686,918

99.02

24,816,004

0.98

64.48%

1,062,741

10. To re-elect Michael Mire

2,504,390,132

98.89

28,100,826

1.11

64.48%

1,077,876

11. To re-elect Sir Adrian Montague

2,503,914,388

98.91

27,677,057

1.09

64.46%

1,969,120

12. To re-elect Maurice Tulloch

2,526,807,364

99.77

5,790,086

0.23

64.48%

978,284

13. To re-appoint PricewaterhouseCoopers LLP as Auditor of the Company

2,488,235,569

99.78

5,527,965

0.22

63.49%

39,813,816

14. To authorise the Audit Committee to determine the Auditor’s remuneration

2,524,769,760

99.68

8,061,433

0.32

64.49%

745,517

15. To authorise the Company and its subsidiaries to make political donations and incur political expenditure

2,486,239,047

98.17

46,384,051

1.83

64.48%

922,530

16. To authorise the directors of the Company to allot ordinary shares

2,407,803,264

95.06

124,937,111

4.94

64.48%

832,890

17. Disapplication of pre-emption rights on allotment of ordinary shares*

2,522,354,842

99.62

9,693,972

0.38

64.47%

1,529,910

18. Disapplication of pre-emption rights

– specified capital projects*

2,474,531,776

97.73

57,465,646

2.27

64.47%

1,581,906

19. To authorise the directors to allot ordinary shares in respect of Solvency II Instruments

2,484,119,968

98.10

48,008,865

1.90

64.47%

1,433,573

20. Disapplication of pre-emption rights –

Solvency II Instruments*

2,476,376,633

97.80

55,652,661

2.20

64.47%

1,538,672

21. Authority to allot sterling new preference shares

2,525,996,071

99.74

6,577,864

0.26

64.48%

1,006,725

22. Disapplication of pre-emption rights – sterling new preference shares*

2,519,774,126

99.50

12,592,973

0.50

64.48%

1,210,778

23. To authorise the Company to purchase its own ordinary shares*

2,476,748,633

97.88

53,686,842

2.12

64.43%

3,143,857

24. To authorise the Company to purchase its own 8 3/4% preference shares*

2,518,463,539

99.53

11,858,689

0.47

64.42%

3,256,639

25. To authorise the Company to purchase its own 8 3/8% preference shares*

2,518,454,352

99.53

11,852,347

0.47

64.42%

3,275,389

26. To authorise the Company to call general meetings other than an Annual General Meeting on not less than 14 clear days’ notice*

2,375,512,073

93.77

157,501,218

6.23

64.49%

463,539